Table 2.
Test | Manufacturer | Method | HPV types detected | Information obtained from test |
---|---|---|---|---|
Hybrid capture 2 | Qiagen (Valencia, California) | Signal amplification | 13 high risk HPV DNA types | Indication of a high risk HPV type present |
Cervista™ HPV HR test | Hologic (Bedford, MA) | Probe amplification | 14 High Risk HPV DNA types | Indication of a high risk HPV type present |
Cervista™ 16/18 HPV test | Hologic (Bedford, MA) | Probe amplification | HPV 16/18 (DNA) | Indication of presence of HPV 16/18 |
Aptima HPV | GenProbe (San Diego, CA) | Target amplification | 14 high risk HPV types (RNA/E6/E7) | Indication of a high risk HPV type present |
Cobas 4800 HPV test | Roche molecular systems (Pleasanton, CA) | Target amplification | 14 high risk HPV (DNA/L1 region) | Indicates which high risk is present |
Approved by FDA in United States or by Health Canada.